[Effects by androgen suppression with luteinizing hormone on cognitive functions in men treated for cancer of

C Nedelec1, S Ragot, J Irani

  • 1Service de neurologie, centre hospitalier de la Rochelle, Poitiers, France.

Abstract

Insights

Androgen suppression therapy for prostate cancer did not impair cognitive functions like memory and attention in men. Visual memory and number memory tests showed significant improvements after 12 months of treatment.

Area of Science:

  • Oncology
  • Neuroscience
  • Endocrinology

Background:

  • Prostate cancer treatment often involves androgen suppression therapy.
  • Potential side effects of androgen suppression on cognitive functions require investigation.

Purpose of the Study:

  • To evaluate the impact of androgen suppression on cognitive functions, specifically memory and attention, in men with prostate cancer.

Main Methods:

  • A prospective study involving 18 men treated with luteinizing hormone-releasing hormone (LH-RH) analogues for prostate cancer.
  • Cognitive assessments including Mini Mental State (MMS), memory tests (Grober-Buschke, Rey Test), and attention/executive tests (Trail Making Test, MADRS) were conducted before and at 6 and 12 months post-treatment.

Main Results:

  • 14 patients were eligible for analysis.
  • Visual memory (Rey Test) significantly improved at 6 and 12 months (p<0.001, p<0.02).
  • Inversed number memory (WAIS) also improved after 6 months (p<0.03).

Conclusions:

  • Androgen suppression therapy for prostate cancer did not lead to cognitive impairment over 12 months.
  • Global cognitive performance was preserved, with some aspects of memory showing improvement.
  • Further larger prospective studies are warranted.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...